Predicting inhaled corticosteroid response in asthma with two associated SNPs

Pharmacogenomics Journal

Volumn 13, Issue 4, 2013, Pages 306-311

  McGeachie, M J ^a,b,c   Wu, A C ^a,b,c   Chang, H H ^a,c,d   Lima, J J ^e   Peters, S P ^f   Tantisira, K G ^a,b,c  

^a LABORATORY FOR MOLECULAR MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^e NEMOURS CHILDREN S CLINIC   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Asthma; Glucocorticoids; Pharmacogenetics; Predictive modeling

Indexed keywords

CORTICOSTEROID; SALMETEROL;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASTHMA; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STEROID THERAPY;

EID: 84881121058     PISSN: 1470269X     EISSN: 14731150     Source Type: Journal    
DOI: 10.1038/tpj.2012.15     Document Type: Article

References (37)

1. Association AL. Trends in Asthma Morbidity and Mortality. American Lung Association, Services EaSURaP: Washington, DC, 2010.
2. Expert Panel Report 3 (EPR-3). Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol 2007; 120(5 Suppl): S94-S138.
3. Szefler SJ, Martin RJ, King TS, Boushey HA, Cherniack RM, Chinchilli VM. et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2002; 109: 410-418.
4. Tantisira KG, Lake S, Silverman ES, Palmer LJ, Lazarus R, Silverman EK et al. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. Hum Mol Genet 2004; 13: 1353-1359.
5. Tantisira KG, Lasky-Su J, Harada M, Murphy A, Litonjua AA, Himes BE et al. Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma. N Engl J Med 2011; 365: 1173-1183.
6. Kim WJ, Sheen SS, Kim TH, Huh JW, Lee JH, Kim EK et al. Association between CRHR1 polymorphism and improved lung function in response to inhaled corticosteroid in patients with COPD. Respirology 2009; 14: 260-263.
7. Jones TS, Kaste SC, Liu W, Cheng C, Yang W, Tantisira KG et al. CRHR1 polymorphisms predict bone density in survivors of acute lymphoblastic leukemia. J Clin Oncol 2008; 26: 3031-3037.
8. Licinio J, O'Kirwan F, Irizarry K, Merriman B, Thakur S, Jepson R et al. Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans. Mol Psychiatry 2004; 9: 1075-1082.
9. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics-2002. J Allergy Clin Immunol 2002; 110(5 Suppl): S141-S219.
10. Wu AC, Tantisira K, Li L, Schuemann B, Weiss S. Repeatability of response to asthma medications. J Allergy Clin Immunol 2009; 123: 385-390.
11. Tantisira KG, Fuhlbrigge AL, Tonascia J, Van Natta M, Zeiger RS, Strunk RC et al. Bronchodilation and bronchoconstriction: predictors of future lung function in childhood asthma. J Allergy Clin Immunol 2006; 117: 1264-1271.
12. Liu H, Li J, Wong L. Use of extreme patient samples for outcome prediction from gene expression data. Bioinformatics 2005; 21: 3377-3384.
13. Himes BE, Wu AC, Duan QL, Klanderman B, Litonjua AA, Tantisira K et al. Predicting response to short-acting bronchodilator medication using Bayesian networks. Pharmacogenomics 2009; 10: 1393-1412.
14. Lazarus SC, Boushey HA, Fahy JV, Chinchilli VM, Lemanske Jr RF, Sorkness CA et al. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. JAMA 2001; 285: 2583-2593.
15. Lemanske Jr RF, Sorkness CA, Mauger EA, Lazarus SC, Boushey HA, Fahy JV et al. Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial. JAMA 2001; 285: 2594-2603.
16. Peters SP, Anthonisen N, Castro M, Holbrook JT, Irvin CG, Smith LJ et al. Randomized comparison of strategies for reducing treatment in mild persistent asthma. N Engl J Med 2007; 356: 2027-2039.
17. Boushey HA, Sorkness CA, King TS, Sullivan SD, Fahy JV, Lazarus SC et al. Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med 2005; 352: 1519-1528.
18. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 2008; 40: 161-169.
19. A map of human genome variation from population-scale sequencing. Nature 2010; 467: 1061-1073.
20. Kass RE, Raftery AE. Bayes Factors. J Am Stat Assoc 1995; 90: 773-795.
21. Sebastiani P, Abad M, Ramoni MF. Bayesian Networks for Genomic Analysis. In: Dougherty ER, Shmulevich I, Chen J, Wang ZJ (eds). Genomic Signal Processing and Statistics 2005 p. 281-320.
22. Good I. The Bayes/Non-Bayes compromise: A brief review. J Am Stat Assoc 1992; 87: 597-606.
23. Lauritzen SL, Wermuth N. Graphical models for association between variables, some of which are quantitative and some qualitative. Ann Stat 1989; 17: 31-57.
24. Cowell RG. Local propagation in conditional gaussian bayesian networks. Machine Learn Res 2005; 6: 1517-1550.
25. Lasko TA, Bhagwat JG, Zou KH, Ohno-Machado L. The use of receiver operating characteristic curves in biomedical informatics. J Biomed Inform 2005; 38: 404-415.
26. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-845.
27. McGeachie M, Ramoni RL, Mychaleckyj JC, Furie KL, Dreyfuss JM, Liu Y et al. Integrative predictive model of coronary artery calcification in atherosclerosis. Circulation 2009; 120: 2448-2454.
28. Sebastiani P, Ramoni MF, Nolan V, Baldwin CT, Steinberg MH. Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nat Genet 2005; 37: 435-440.
29. Stefansson H, Helgason A, Thorleifsson G, Steinthorsdottir V, Masson G, Barnard J et al. A common inversion under selection in Europeans. Nat Genet 2005; 37: 129-137.
30. Tantisira KG, Lazarus R, Litonjua AA, Klanderman B, Weiss ST. Chromosome 17: association of a large inversion polymorphism with corticosteroid response in asthma. Pharmacogenet Genomics 2008; 18: 733-737.
31. Wu AC, Himes BE, Lasky-Su J, Litonjua A, Li L, Lange C et al. Development of a Pharmacogenetic Predictive Test in asthma: proof of concept. Pharmacogenet Genomics 2010; 20: 86-93.
32. Marsh S, Hoskins JM. Irinotecan pharmacogenomics. Pharmacogenomics 2010; 11: 1003-1010.
33. Meckley LM, Wittkowsky AK, Rieder MJ, Rettie AE, Veenstra DL. An analysis of the relative effects of VKORC1 and CYP2C9 variants on anticoagulation related outcomes in warfarin-treated patients. Thromb Haemost 2008; 100: 229-239.
34. Meschia JF. Pharmacogenetics and stroke. Stroke 2009; 40: 3641-3645.
35. Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT et al. Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes. Circulation 2009; 119: 2553-2560.
36. Ziegler S, Schillinger M, Funk M, Felber K, Exner M, Mlekusch W et al. Association of a functional polymorphism in the clopidogrel target receptor gene, P2Y12, and the risk for ischemic cerebrovascular events in patients with peripheral artery disease. Stroke 2005; 36: 1394-1399.
37. Link E, Parish S, Armitage J, Bowman L, Heath S, Matsuda F et al. SLCO1B1 variants and statin-induced myopathy-a genomewide study. N Engl J Med 2008; 359: 789-799.